Aripiprazole and Pre-eclampsia aggravated - a phase IV clinical study of FDA data

Summary:

Pre-eclampsia aggravated is reported as a side effect among people who take Aripiprazole (aripiprazole), especially for people who are 30-39 old, have been taking the drug for 1 - 6 months also take Symbicort, and have Schizophrenia.

The phase IV clinical study analyzes which people have Pre-eclampsia aggravated when taking Aripiprazole. It is created by eHealthMe based on reports of 38,853 people who have side effects when taking Aripiprazole from the FDA, and is updated regularly.

What is Aripiprazole?

Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.

What is Pre-eclampsia aggravated?

Pre-eclampsia aggravated (serious high blood pressure and significant amounts of protein in the urine of a pregnant woman) is found to be associated with 379 drugs and 284 conditions by eHealthMe. Check the latest studies of Pre-eclampsia aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

38,853 people reported to have side effects when taking Aripiprazole.
Among them, 34 people (0.09%) have Pre-eclampsia aggravated.

Could Aripiprazole cause Pre-eclampsia aggravated?

Among these 34 people:

How long have people been on Aripiprazole when they have Pre-eclampsia aggravated? *

What is the age of people who have Pre-eclampsia aggravated when taking Aripiprazole? *

What are other drugs people take besides Aripiprazole? *

What are other side effects people have besides Pre-eclampsia aggravated? *

Maternal Exposure During Pregnancy (use of substance during pregnancy): 19 people, 55.88%
Gestational Diabetes (diabetes in pregnancy): 12 people, 35.29%
Live Birth: 8 people, 23.53%
Premature Delivery: 7 people, 20.59%
Weight Loss: 6 people, 17.65%
Anogenital Warts: 4 people, 11.76%
Normal Newborn: 4 people, 11.76%
Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 4 people, 11.76%
Prolonged Labor: 4 people, 11.76%
Nausea (feeling of having an urge to vomit): 3 people, 8.82%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 9 people, 26.47%
Stress And Anxiety: 6 people, 17.65%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 6 people, 17.65%
Asthma: 5 people, 14.71%
Diabetes: 4 people, 11.76%
Nausea (feeling of having an urge to vomit): 3 people, 8.82%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 2 people, 5.88%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 2 people, 5.88%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Aripiprazole and have Pre-eclampsia aggravated?

- Check whether Pre-eclampsia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aripiprazole:

Aripiprazole (39,143 reports)

Browse all side effects of Aripiprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pre-eclampsia aggravated:

Pre-eclampsia aggravated (379 drugs)

Browse all the conditions that are associated with Pre-eclampsia aggravated:

Pre-eclampsia aggravated (284 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Aripiprazole) and Aripiprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.